ascopubs.org

Nemesis: Non-inferiority meta-analysis of selective internal radiation therapy with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma: A ...

Tumor mutation burden in biliary tract cancers with ERBB family or DNA damage repair gene mutations. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not ...
RAPS

When can Non-Inferiority Trials Establish Efficacy? FDA Explains With Guidance

The US Food and Drug Administration (FDA) on Monday finalized guidance to pharmaceutical and biotech sponsors looking for more advice on when non-inferiority studies demonstrating effectiveness of an ...
BMJ

Economic evaluations in ‘non-inferiority’ trials: can costs guide decisions between surgical and non-surgical interventions?

Correspondence to Professor Steven M McPhail, Australian Centre for Health Services Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia; steven.mcphail{at}qut.edu.au ...
FierceBiotech

Press Release: Repros Therapeutics Androxal Shows Noninferiority In Interim Phase 3 Analysis

Repros Therapeutics Androxal Shows Noninferiority In Interim Phase 3 Analysis THE WOODLANDS, Texas -- Repros Therapeutics Inc. announced interim results of a U.S. Phase 3 study of Androxalâ„¢, an oral ...